NFDI4DS | UHH-SEMS - Publication Details

Emilie Thibaudeau

ORCID: 0000-0002-3261-0263

Publications

Citations

Views

---

Saved

---

About

Contact & Profiles

A5109811437

Research Areas

Intraperitoneal and Appendiceal Malignancies
Colorectal Cancer Surgical Treatments
Appendicitis Diagnosis and Management
Ovarian cancer diagnosis and treatment
Gastric Cancer Management and Outcomes
Stoma care and complications
Hepatocellular Carcinoma Treatment and Prognosis
Hernia repair and management
Gastrointestinal Tumor Research and Treatment
Colorectal and Anal Carcinomas
Diverticular Disease and Complications
Cancer Immunotherapy and Biomarkers
Anorectal Disease Treatments and Outcomes
Occupational and environmental lung diseases
Metastasis and carcinoma case studies
Pleural and Pulmonary Diseases
Immune Cell Function and Interaction
Pancreatic and Hepatic Oncology Research
Pelvic and Acetabular Injuries
Intestinal and Peritoneal Adhesions
Neuroendocrine Tumor Research Advances
Minimally Invasive Surgical Techniques
Urologic and reproductive health conditions
Colorectal Cancer Screening and Detection
Immunotherapy and Immune Responses

Institut de Cancérologie de l'Ouest
2017-2025

Nantes Université
2022

Institut Génétique Nantes Atlantique
2016-2019

Hôpital Lyon Sud
2018

Lyon College
2018

Cancéropôle Grand Ouest
2015

Centre Hospitalier Universitaire d'Angers
2010-2014

Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 study

OPENALEX - Publications

Diane Goèré Olivier Gléhen François Quénet Jean‐Marc Guilloit Jean-Marc Béréder and 24 more

10.1016/s1470-2045(20)30322-3 article EN publisher-specific-oa The Lancet Oncology 2020-07-24

Hyperthermic intraperitoneal chemotherapy in colorectal cancer

OPENALEX - Publications

Oliver M. Fisher Chris Brown Jesús Esquivel Stein Gunnar Larsen Winston Liauw and 54 more

This study evaluated the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastases (pmCRC) a large international data set patients.

10.1093/bjsopen/zrae017 article EN cc-by BJS Open 2024-05-08

Deep Learning-Based Lesion Detection in Endoscopy: A Systematic Literature Review

OPENALEX - Publications

Naim Rochmawati Chastine Fatichah Bilqis Amaliah Agus Budi Raharjo Frédéric Dumont and 2 more

10.1109/access.2025.3548167 article EN cc-by IEEE Access 2025-01-01

Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database

OPENALEX - Publications

Vahan Képénékian D. Élias Guillaume Passot Eliane Mery-Lamarche Diane Goèré and 57 more

10.1016/j.ejca.2016.06.002 article EN European Journal of Cancer 2016-07-26

Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE)

OPENALEX - Publications

Guillaume Passot F. Dumont Diane Goèré C. Arvieux Pascal Rousset and 23 more

Abstract Background The peritoneal cancer index (PCI) is a comparative prognostic factor for colorectal metastasis (CRPM). ability of laparoscopy to determine the PCI in consideration cytoreductive surgery remains undetermined, and this study was designed compare it with laparotomy. Methods A prospective multicentre conducted patients no known CRPM, but at risk disease. Surgery began laparoscopic exploration followed by open PCI. Concordance between assessment evaluated diagnosis CRPM...

10.1002/bjs.10723 article EN British journal of surgery 2018-03-26

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

OPENALEX - Publications

Juliette Eugène Nicolas Jouand Kathleen Ducoin Delphine Dansette Romain Oger and 19 more

10.1038/s41379-019-0322-9 article EN publisher-specific-oa Modern Pathology 2019-08-13

A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

OPENALEX - Publications

Laurent Villeneuve Arnaud Thivolet Naoual Bakrin Faheez Mohamed S. Isaac and 88 more

10.1016/j.ejso.2016.03.015 article EN European Journal of Surgical Oncology 2016-03-28

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

OPENALEX - Publications

Frédéric Mercier François Dagbert Marc Pocard Diane Goèré F. Quénet and 93 more

Pseudomyxoma peritonei (PMP) is a rare clinical condition characterized by mucinous ascites, typically related to appendiceal or ovarian tumours. Current standard treatment involves cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), but recurrences occur in 20-30 per cent of patients. The aim this study was define the timing patterns recurrence provide basis for modifying follow-up these patients.This observational examined prospectively developed multicentre...

10.1002/bjs5.97 article EN cc-by BJS Open 2018-09-27

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin

OPENALEX - Publications

Jean‐Baptiste Delhorme François Séverac Gerlinde Avérous Olivier Gléhen Guillaume Passot and 95 more

The prognostic value of the primary neoplasm responsible for pseudomyxoma peritonei (PMP) remains poorly studied. aim this study was to determine prognosis patients with extra-appendicular PMP (EA-PMP) treated optimally complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).All CCRS HIPEC between 1994 2016 were selected retrospectively from a French multicentre database. Patients EA-PMP had pathologically confirmed non-neoplastic appendices matched in 1 :...

10.1002/bjs.10716 article EN British journal of surgery 2018-02-07

A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers

OPENALEX - Publications

Frédéric Dumont Christophe Passot Jean‐Luc Raoul Vahan Képénékian Bénédicte Lelièvre and 8 more

10.1016/j.ejca.2020.09.010 article EN European Journal of Cancer 2020-10-08

Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study)

OPENALEX - Publications

Pierre‐Emmanuel Bonnot Alexandru Lintis Frédéric Mercier Nazim Benzerdjeb Guillaume Passot and 71 more

Abstract Background The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. prognosis for patients with peritoneal metastases remains poor and the role cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC) controversial. aim was to clarify impact PCC treated by CRS or without HIPEC. Methods All from cancer HIPEC, in 19 French centres, between 1989 2014, were identified institutional databases. Clinicopathological characteristics outcomes compared...

10.1093/bjs/znab200 article EN British journal of surgery 2021-09-08

Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study

OPENALEX - Publications

Abdelkader Taïbi Olivia Sgarbură Martin Hübner Sylvia M. Bardet Mohammad Alyami and 11 more

10.1245/s10434-022-11577-2 article EN Annals of Surgical Oncology 2022-03-22

LBA62 Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44

OPENALEX - Publications

A. Lambert Olivier Bouché Ahmet Ayav J-B. Bachet Lilian Schwarz and 8 more

10.1016/j.annonc.2024.08.2304 article EN Annals of Oncology 2024-09-01

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study

OPENALEX - Publications

Sanket Mehta Lilian Schwarz John Spiliotis Mao‐Chih Hsieh Eduardo Hiroshi Akaishi and 81 more

10.1016/j.ejso.2018.05.021 article EN European Journal of Surgical Oncology 2018-05-28

Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design

OPENALEX - Publications

Frédéric Dumont Hélène Senellart F Pein L. Campion Olivier Gléhen and 3 more

Abstract Background The annual incidence of gastrointestinal carcinomas (stomach, small bowel, colon and rectum) is increasing in Western countries, reaching 50,000 new cases each year France. Peritoneal carcinomatosis (PC) diagnosed 15% these patients. Complete cytoreductive surgery (CCS) plus Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) the only therapy that can offer patients with PC a chance for long-term survival 5 overall (OS) rate 30–60% versus 0–5% systemic chemotherapy alone....

10.1515/pp-2018-0120 article EN cc-by Pleura and Peritoneum 2018-09-15

Can inter-observer consistency be achieved in the laparoscopic assessment of the peritoneal carcinomatosis index score in peritoneal metastasis? A pilot study

OPENALEX - Publications

Alexis Astruc Valérie Seegers Frédéric Dumont Cécile Loaec Emilie Thibaudeau and 4 more

Abstract Objectives The main prognostic factor for peritoneal metastasis (PM) is the complete resection of disease during cytoreductive surgery. Accurate patient selection therefore essential determining eligibility this type carcinomatosis index (PCI) a widely used tool assessing extent carcinomatosis. This study aimed to evaluate inter-observer reproducibility PCI assessments via laparoscopy and identify factors influencing reproducibility. Methods Between November 2020 2022, 25...

10.1515/pp-2024-0015 article EN cc-by Pleura and Peritoneum 2025-03-01

Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey

OPENALEX - Publications

Gwénaël Ferron Lucía Simón-Vicente Frédéric Guyon Olivier Gléhen Diane Goèré and 45 more

10.1016/j.ejso.2015.07.012 article EN European Journal of Surgical Oncology 2015-07-29

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study

OPENALEX - Publications

Mohammad Alyami Peter W. Lundberg Vahan Képénékian Diane Goèré Jean-Marc Béréder and 22 more

10.1245/s10434-016-5519-2 article EN Annals of Surgical Oncology 2016-09-06

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study

OPENALEX - Publications

Séverine Valmary‐Degano Prudence Colpart Laurent Villeneuve Franck Monnien Loubna Mhamdi and 93 more

10.1016/j.ejso.2017.05.009 article EN European Journal of Surgical Oncology 2017-05-18

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups

OPENALEX - Publications

Iris Amblard Frédéric Mercier David L. Bartlett Steven A. Ahrendt K.W. Lee and 92 more

10.1016/j.ejso.2018.04.023 article EN European Journal of Surgical Oncology 2018-06-19

Management of acute malignant large-bowel obstruction with self-expanding metal stent

OPENALEX - Publications

Frédéric Branger Emilie Thibaudeau S. Mucci-Hennekinne E Metivier-Cesbron Karina Vychnevskaia and 2 more

10.1007/s00384-010-1003-9 article EN International Journal of Colorectal Disease 2010-07-06

Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis

OPENALEX - Publications

Nazim Benzerdjeb Peggy Dartigues Vahan Képénékian Séverine Valmary‐Degano Eliane Mery-Lamarche and 90 more

10.1007/s00428-021-03099-1 article EN Virchows Archiv 2021-04-14

Rectal Metastasis of Prostate Cancer: About a Case

OPENALEX - Publications

Aurélien Venara Emilie Thibaudeau Souhil Lebdai S. Mucci C. Ridereau‐Zins and 2 more

Prostate adenocarcinomas present a high risk of metastasis. We report case an atypical prostate cancer A male patient presented prostatic adenocarcinoma treated by surgery. biological recurrence was discovered during the follow-up increased rate Specific Antigen (PSA) and hormonotherapy. Several months later, there re-increase PSA rate. The CT scan showed radiation proctitis aspect. An intermittent hormonotherapy decided. Six he abdominal pain. Examinations were performed rectal...

10.4021/jocmr2010.05.309w article EN cc-by-nc Journal of Clinical Medicine Research 2010-01-01

PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial

OPENALEX - Publications

Frédéric Dumont Vahan Képénékian Christophe Passot Anne-Cécile Ezanno-Manasterski Marc Pocard and 10 more

10.1016/j.ejso.2024.108468 article EN European Journal of Surgical Oncology 2024-06-05

Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study

OPENALEX - Publications

G. Lorimier Valérie Seegers Marie Coudert Denis Dupoiron Emilie Thibaudeau and 8 more

10.1016/j.ejso.2018.08.012 article EN European Journal of Surgical Oncology 2018-08-29

Coming Soon ...